Yokomizo, Ryo
Kato, Tsuguhiko
Urayama, Kevin Y.
Nakamura, Akari
Sato, Makoto
Nasu, Risa
Hine, Maaya
Kishi, Hiroshi
Sago, Haruhiko
Okamoto, Aikou
Umezawa, Akihiro
Funding for this research was provided by:
National Center for Child Health and Development
Article History
Received: 13 February 2024
Accepted: 18 June 2025
First Online: 1 July 2025
Declarations
:
: The authors declare no competing interests.
: AN, MS, RN, and MH are employees of MTI Ltd. who developed “Luna Luna”. AU is a co-researcher with MTI Ltd., Terumo Corp., CellSeed Inc., ROHTO Pharmaceutical Ltd., SEKISUI MEDICAL Ltd., Metcela Inc., PhoenixBio Ltd., Dai Nippon Printing Ltd. The remaining authors declare no competing interests.
: Ethics approval for the implementation of the present study was obtained from the ethics committee at the National Center for Child Health and Development of Japan (approval number: 2020 − 175). This research was carried out in accordance with Ethical Guidelines for Medical and Health Research Involving Human Subjects. All participants in this study agreed to be enrolled by selecting the consent button in at least one of the three applications of the Luna Luna platform (Luna Luna, Luna Luna Taion-note, and Luna Luna Baby) which equates to signing the informed consent form before inclusion.